Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
10.52
+0.08 (0.77%)
Feb 3, 2026, 3:00 PM CST

SHA:600420 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-6,2125,9736,1484,284
Short-Term Investments
-1,431---
Cash & Short-Term Investments
4,1417,6435,9736,1484,284
Cash Growth
-45.82%27.97%-2.86%43.51%15.18%
Accounts Receivable
-1,3612,0512,6563,048
Other Receivables
-85.5584.0792.8596.91
Receivables
-1,4472,1352,7483,144
Inventory
-2,2092,2802,4403,072
Prepaid Expenses
-70.2961.6347.6940.21
Other Current Assets
-315.43207.49300.4345.15
Total Current Assets
-11,68410,65711,68410,886
Property, Plant & Equipment
-5,5505,8856,2466,511
Long-Term Investments
-1,3161,431376.22370.77
Goodwill
-160.15160.15160.15160.15
Other Intangible Assets
-591.29511.18517.08549.09
Long-Term Deferred Tax Assets
-103.15153.13239.09188.75
Long-Term Deferred Charges
-333.66331.74227.83144.74
Other Long-Term Assets
-216.67223.65179.17259.22
Total Assets
-19,95619,35219,63019,070
Accounts Payable
-1,1031,3741,2491,542
Accrued Expenses
-1,4201,5951,6751,670
Short-Term Debt
-50.0545.05321.142,014
Current Portion of Long-Term Debt
-1,031-48.37539.63
Current Portion of Leases
-8.8610.69.8640.13
Current Income Taxes Payable
-72.5129.9537.9430.86
Current Unearned Revenue
-193.33244.6344.17201.23
Other Current Liabilities
-465.17480.59509.97804.25
Total Current Liabilities
-4,3443,7804,1966,843
Long-Term Debt
--1,0312,9551,547
Long-Term Leases
-47.9457.9768.5743
Long-Term Unearned Revenue
-113.99122.8138.01140.33
Pension & Post-Retirement Benefits
-0.360.520.570.84
Long-Term Deferred Tax Liabilities
-70.7722.15119.55126.19
Other Long-Term Liabilities
-56.96---
Total Liabilities
-4,6345,0147,4788,700
Common Stock
-1,3411,3411,1721,027
Additional Paid-In Capital
-5,2045,2043,5872,545
Retained Earnings
-6,6605,8455,2874,762
Comprehensive Income & Other
--0.91-1.09259.34258.88
Total Common Equity
13,63813,20412,38810,3058,593
Minority Interest
-2,1181,9501,8471,777
Shareholders' Equity
15,69915,32214,33812,15310,370
Total Liabilities & Equity
-19,95619,35219,63019,070
Total Debt
47.711,1381,1453,4034,184
Net Cash (Debt)
4,0946,5054,8282,74599.84
Net Cash Growth
-37.07%34.74%75.89%2649.36%-
Net Cash Per Share
3.054.853.792.370.08
Filing Date Shares Outstanding
1,3411,3411,3411,1721,027
Total Common Shares Outstanding
1,3411,3411,3411,1721,027
Working Capital
-7,3406,8777,4894,044
Book Value Per Share
10.179.859.248.578.11
Tangible Book Value
12,72812,45211,7179,6287,884
Tangible Book Value Per Share
9.499.288.747.997.42
Buildings
-4,4914,4723,9453,874
Machinery
-8,4538,3708,1847,920
Construction In Progress
-142.68101.35642.37585.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.